Chad M. Cohen, Chief Financial Officer at Adaptive Biotechnologies Corp (ADPT), sold 23,738 shares at $33.48 ($804K) on 2021-08-11, disclosed to the SEC on 2021-08-12.
Open-market sale of $804k ADPT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.00 | 5,000 | $175K | 21.8% |
| 2 | $33.48 | 8,738 | $293K | 36.4% |
| 3 | $33.48 | 8,738 | $293K | 36.4% |
| 4 | $34.47 | 1,262 | $44K | 5.4% |
| Total | $33.85 avg | 23,738 | $804K | 100% |
| Filing → |
| ADPT | SELL | 2021-10-07 | $324K | — | Filing → |
| ADPT | SELL | 2021-09-09 | $940K | — | Filing → |
| ADPT | SELL | 2021-07-08 | $1.2M | — | Filing → |